LETTER TO THE EDITOR

Extended benefits of TAVR in young patients with low-intermediate risk score: proceed with care

EuroIntervention 2018;14:e485 published online e-edition July 2018. DOI: 10.4244/EIJ-D-18-00236L

Rajkumar Doshi
Rajkumar Doshi, MD, MPH
Department of Cardiology, North Shore University Hospital, Manhasset, NY, USA


I read with great interest the article “In-hospital outcomes after transcatheter or surgical aortic valve replacement in younger patients less than 75 years old: a propensity-matched comparison” by Eggebrecht et al1. The authors revealed similar in-hospital mortality and stroke rates in the propensity score-matched transfemoral-transcatheter aortic valve replacement (TF-TAVR) and surgical aortic valve replacement (SAVR) patients. However, need for permanent pacemaker rates were fourfold higher with TF-TAVR. This study is of significant importance since the indications for TAVR have been increasing following the SURTAVI trial2.

I have a few concerns regarding this study. First, more low-risk patients were included ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Reply to the letter to the editor by Doshi regarding the article “In-hospital outcomes after transcatheter or surgical aortic valve replacement in younger patients less than 75 years old: a propensity-matched comparison”

Latest news